Skip to main content
Top
Published in: Comparative Clinical Pathology 6/2012

01-12-2012 | Original Article

Effect of Crataegus extract on carbon tetrachloride-induced hepatic damage

Authors: Omar M. E. Abdel Salam, Amany A. Sleem, Nermeen Shafee

Published in: Comparative Clinical Pathology | Issue 6/2012

Login to get access

Abstract

The current study evaluated the effect of a standardized Crataegus extract on liver injury induced by acute carbon tetrachloride (CCl4) administration in rats. Crataegus extract (10, 20 or 40 mg/kg), silymarin (25 mg/kg) or saline (control) was given once daily orally simultaneously with CCl4 and for 1 week thereafter. Crataegus extract given at the above doses reduced serum alanine aminotransferase (ALT) levels by 28.8, 31.8 and 36.4%, respectively, when compared to the CCl4 control group. Serum aspartate aminotransferase (AST) levels decreased by 14.3, 15.5 and 20.6%, respectively, while alkaline phosphatase (ALP) decreased by 21.8% by the extract at 40 mg/kg. The administration of silymarin reduced ALT, AST and ALP levels by 66.8, 64.9 and 60%, respectively. In CCl4-treated rats, the increase in serum nitric oxide (nitrite/nitrate) level, the histological liver damage as well as the decrease in mucopolysaccharide and protein content of hepatocytes were all improved by Crataegus extract at 40 mg/kg and almost normalized by silymarin. These results suggest that treatment with Crataegus extract improves the CCl4-induced hepatic injury in rats.
Literature
go back to reference Abdel Salam OME, Sleem AA, Omara EA, Hassan NS (2007) Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats. Drug Target Insights 2:19–27PubMed Abdel Salam OME, Sleem AA, Omara EA, Hassan NS (2007) Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats. Drug Target Insights 2:19–27PubMed
go back to reference Ahumada C, Sáenz T, García D, De La Puerta R, Fernandez A, Martinez E (1997) The effects of a triterpene fraction isolated from Crataegus monogyna Jacq. on different acute inflammation models in rats and mice. Leucocyte migration and phospholipase A2 inhibition. J Pharm Pharmacol 49:329–331PubMedCrossRef Ahumada C, Sáenz T, García D, De La Puerta R, Fernandez A, Martinez E (1997) The effects of a triterpene fraction isolated from Crataegus monogyna Jacq. on different acute inflammation models in rats and mice. Leucocyte migration and phospholipase A2 inhibition. J Pharm Pharmacol 49:329–331PubMedCrossRef
go back to reference Anselm E, Socorro VF, Dal-Ros S, Schott C, Bronner C, Schini-Kerth VB (2009) Crataegus special extract WS 1442 causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of endothelial NO synthase but not via activation of estrogen receptors. J Cardiovasc Pharmacol 53:253–260PubMedCrossRef Anselm E, Socorro VF, Dal-Ros S, Schott C, Bronner C, Schini-Kerth VB (2009) Crataegus special extract WS 1442 causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of endothelial NO synthase but not via activation of estrogen receptors. J Cardiovasc Pharmacol 53:253–260PubMedCrossRef
go back to reference Bahorun T, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M (1996) Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung 46:1086–1089PubMed Bahorun T, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M (1996) Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung 46:1086–1089PubMed
go back to reference Belfield A, Goldberg DM (1971) Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme 12:561–573PubMed Belfield A, Goldberg DM (1971) Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme 12:561–573PubMed
go back to reference Busse WR, Juretzek W, Koch E (2005) Hawthorn (Crataegus). In: Coates P, Blackman MR, Cragg G (eds) Encyclopedia of dietary supplements. Marcel Dekker, New York, pp 337–347 Busse WR, Juretzek W, Koch E (2005) Hawthorn (Crataegus). In: Coates P, Blackman MR, Cragg G (eds) Encyclopedia of dietary supplements. Marcel Dekker, New York, pp 337–347
go back to reference Campo GM, Squadrito E, Ceccarelli S, Calo M, Avenoso A, Campo S (2001) Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant. Free Free Radical Res 34:379–393CrossRef Campo GM, Squadrito E, Ceccarelli S, Calo M, Avenoso A, Campo S (2001) Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant. Free Free Radical Res 34:379–393CrossRef
go back to reference Chazouillères O, Ballet F, Chrétien Y, Marteau P, Rey C, Maillard D, Poupon R (1989) Protective effect of vasodilators on liver function after long hypothermic preservation: a study in the isolated perfused rat liver. Hepatology 9(6):824–829PubMedCrossRef Chazouillères O, Ballet F, Chrétien Y, Marteau P, Rey C, Maillard D, Poupon R (1989) Protective effect of vasodilators on liver function after long hypothermic preservation: a study in the isolated perfused rat liver. Hepatology 9(6):824–829PubMedCrossRef
go back to reference Chen ZY, Zhang ZS, Kwan KY, Zhu M, Ho WK, Huang Y (1998) Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 63:1983–1991PubMedCrossRef Chen ZY, Zhang ZS, Kwan KY, Zhu M, Ho WK, Huang Y (1998) Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 63:1983–1991PubMedCrossRef
go back to reference Crowley LV (1967) The Reitman–Frankel colorimetric transaminase procedure in suspected myocardial infarction. Clin Chem 13:482–487PubMed Crowley LV (1967) The Reitman–Frankel colorimetric transaminase procedure in suspected myocardial infarction. Clin Chem 13:482–487PubMed
go back to reference Daniele C, Mazzanti G, Pittler MH, Ernst E (2006) Adverse-event profile of Crataegus spp.: a systematic review. Drug Saf 29:523–535PubMedCrossRef Daniele C, Mazzanti G, Pittler MH, Ernst E (2006) Adverse-event profile of Crataegus spp.: a systematic review. Drug Saf 29:523–535PubMedCrossRef
go back to reference De La Puerta R, Martinez E, Bravo L, Ahumada MC (1996) Effect of silymarin on different acute inflammation models and on leukocyte migration. J Pharm Pharmacol 48:968–970CrossRef De La Puerta R, Martinez E, Bravo L, Ahumada MC (1996) Effect of silymarin on different acute inflammation models and on leukocyte migration. J Pharm Pharmacol 48:968–970CrossRef
go back to reference Dehmlow C, Murawski N, De Groot H (1996) Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 58:1591–1600PubMedCrossRef Dehmlow C, Murawski N, De Groot H (1996) Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 58:1591–1600PubMedCrossRef
go back to reference Drury RVA, Walligton EA (1980) Carltons histological techniques, 5th edn. Oxford University Press, New York, Pronto, p 206 Drury RVA, Walligton EA (1980) Carltons histological techniques, 5th edn. Oxford University Press, New York, Pronto, p 206
go back to reference Farghali H, Kamenikova L, Hynie S, Kmonickova E (2000) Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 41:231–237PubMedCrossRef Farghali H, Kamenikova L, Hynie S, Kmonickova E (2000) Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacol Res 41:231–237PubMedCrossRef
go back to reference Fehér J, Lengyel G, Blázovics A (1998) Oxidative stress in the liver and biliary tract diseases. Scand J Gastroenterol Suppl 228:38–46PubMed Fehér J, Lengyel G, Blázovics A (1998) Oxidative stress in the liver and biliary tract diseases. Scand J Gastroenterol Suppl 228:38–46PubMed
go back to reference Flora K, Hahn M, Rosen H, Benner K (1998) Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 93:139–143PubMedCrossRef Flora K, Hahn M, Rosen H, Benner K (1998) Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 93:139–143PubMedCrossRef
go back to reference Fürst R, Zirrgiebel U, Totzke F, Zahler S, Vollmar AM, Koch E (2010) The Crataegus extract WS((R)) 1442 inhibits balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing PDGFR-beta. Atherosclerosis 211:409–417PubMedCrossRef Fürst R, Zirrgiebel U, Totzke F, Zahler S, Vollmar AM, Koch E (2010) The Crataegus extract WS((R)) 1442 inhibits balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing PDGFR-beta. Atherosclerosis 211:409–417PubMedCrossRef
go back to reference Gupta OP, Sing S, Bani S, Sharma N, Malhotra S, Gupta BD (2000) Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase. Phytomedicine 7:21–24PubMedCrossRef Gupta OP, Sing S, Bani S, Sharma N, Malhotra S, Gupta BD (2000) Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase. Phytomedicine 7:21–24PubMedCrossRef
go back to reference Holubarsch CJ, Colucci WS, Meinertz T, Gaus W, Tendera M (2008) Survival and prognosis: investigation of Crataegus extract WS 1442 in CHF (SPICE) trial study group. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur J Heart Fail 10:1255–1263PubMedCrossRef Holubarsch CJ, Colucci WS, Meinertz T, Gaus W, Tendera M (2008) Survival and prognosis: investigation of Crataegus extract WS 1442 in CHF (SPICE) trial study group. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur J Heart Fail 10:1255–1263PubMedCrossRef
go back to reference Hsu CT, Schichijo K, Ito M, Sekine I (1993) The effect of chemical sympathectomy on acute liver injury induced by carbon tetrachloride in spontaneously hypertensive rats. J Auton Nerv Syst 43:91–96PubMedCrossRef Hsu CT, Schichijo K, Ito M, Sekine I (1993) The effect of chemical sympathectomy on acute liver injury induced by carbon tetrachloride in spontaneously hypertensive rats. J Auton Nerv Syst 43:91–96PubMedCrossRef
go back to reference Iwai S, Karim R, Kitano M, Sukata T, Min W, Morimura K (2002) Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury—enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats. J Cancer Lett 179:15–24CrossRef Iwai S, Karim R, Kitano M, Sukata T, Min W, Morimura K (2002) Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury—enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats. J Cancer Lett 179:15–24CrossRef
go back to reference Lucena MI, Andrade RJ, de la Cruz JP, Rodriguez Mendizabal M, Blanco E, Sanchez de la Cuesta F (2002) Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study. Int J Clin Pharmacol Ther 40:2–8PubMed Lucena MI, Andrade RJ, de la Cruz JP, Rodriguez Mendizabal M, Blanco E, Sanchez de la Cuesta F (2002) Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study. Int J Clin Pharmacol Ther 40:2–8PubMed
go back to reference Mac-Manus JPA, Cason JE (1950) Carbohydrate histochemistry studies by acetylation technique. Periodic acid method. J Exp Med 91:651CrossRef Mac-Manus JPA, Cason JE (1950) Carbohydrate histochemistry studies by acetylation technique. Periodic acid method. J Exp Med 91:651CrossRef
go back to reference Mazia D, Drewer PA, Alfert M (1953) The cytochemical staining and measurement of protein with mercaric bromophenol blue. Biol Bull 104:57–67CrossRef Mazia D, Drewer PA, Alfert M (1953) The cytochemical staining and measurement of protein with mercaric bromophenol blue. Biol Bull 104:57–67CrossRef
go back to reference Miller AL (1998) Botanical influences on cardiovascular disease. Altern Med Rev 3:422–431PubMed Miller AL (1998) Botanical influences on cardiovascular disease. Altern Med Rev 3:422–431PubMed
go back to reference Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71PubMedCrossRef Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71PubMedCrossRef
go back to reference Mizumoto M, Arii S, Furutani M, Nakamura T, Ishigami S, Monden K (1997) NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J Surg Res 70:124–133PubMedCrossRef Mizumoto M, Arii S, Furutani M, Nakamura T, Ishigami S, Monden K (1997) NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J Surg Res 70:124–133PubMedCrossRef
go back to reference Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142PubMed Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142PubMed
go back to reference Mourelle M, Muriel P, Favari L, Franco T (1989) Prevention of CCl4-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol 3:183–191PubMedCrossRef Mourelle M, Muriel P, Favari L, Franco T (1989) Prevention of CCl4-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol 3:183–191PubMedCrossRef
go back to reference Muriel P (1998) Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 56:773–779PubMedCrossRef Muriel P (1998) Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 56:773–779PubMedCrossRef
go back to reference Muriel P, Mourelle M (1990) Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol 10:275–279PubMedCrossRef Muriel P, Mourelle M (1990) Prevention by silymarin of membrane alterations in acute CCl4 liver damage. J Appl Toxicol 10:275–279PubMedCrossRef
go back to reference Muriel P, Alba N, Perez-Alvarez VM, Shibayama M, Tsutsumi VK (2001) Comp Biochem Physiol C Toxicol Pharmacol 130:219–226PubMedCrossRef Muriel P, Alba N, Perez-Alvarez VM, Shibayama M, Tsutsumi VK (2001) Comp Biochem Physiol C Toxicol Pharmacol 130:219–226PubMedCrossRef
go back to reference Paget GE, Barnes JM (1964) Toxicity testing. In: Laurence DR, Bacharach AL (eds) Evaluation of drug activities pharmacometics. Academic Press, London, pp 1–135 Paget GE, Barnes JM (1964) Toxicity testing. In: Laurence DR, Bacharach AL (eds) Evaluation of drug activities pharmacometics. Academic Press, London, pp 1–135
go back to reference Pár A, Roth E, Rumi G, Kovacs Z, Nemes J, Mozsik G (2000) Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C. Orv Hetil 141:1655–1659PubMed Pár A, Roth E, Rumi G, Kovacs Z, Nemes J, Mozsik G (2000) Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C. Orv Hetil 141:1655–1659PubMed
go back to reference Pittler MH, Schmidt K, Ernst E (2003) Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 114:665–674PubMedCrossRef Pittler MH, Schmidt K, Ernst E (2003) Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 114:665–674PubMedCrossRef
go back to reference Pöpping S, Rose H, Ionescu I, Fischer Y, Kammermeier H (1995) Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 45:1157–1161PubMed Pöpping S, Rose H, Ionescu I, Fischer Y, Kammermeier H (1995) Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 45:1157–1161PubMed
go back to reference Rakotoarison DA, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M (1997) Antioxidant activities of polyphenolic extracts from flowers, in vitro callus and cell suspension cultures of Crataegus monogyna. Pharmazie 52:60–64PubMed Rakotoarison DA, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M (1997) Antioxidant activities of polyphenolic extracts from flowers, in vitro callus and cell suspension cultures of Crataegus monogyna. Pharmazie 52:60–64PubMed
go back to reference Recknagel RO, Glende EA Jr, Dolak JA, Waller RL (1989) Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 43:139–154PubMedCrossRef Recknagel RO, Glende EA Jr, Dolak JA, Waller RL (1989) Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 43:139–154PubMedCrossRef
go back to reference Salam OM, Sleem AA, Omara EA, Hassan NS (2009) Hepatoprotective effects of misoprostol and silymarin on carbon tetrachloride-induced hepatic damage in rats. Fundam Clin Pharmacol 23:179–188PubMedCrossRef Salam OM, Sleem AA, Omara EA, Hassan NS (2009) Hepatoprotective effects of misoprostol and silymarin on carbon tetrachloride-induced hepatic damage in rats. Fundam Clin Pharmacol 23:179–188PubMedCrossRef
go back to reference Schlegelmilch R, Heywood R (1994) Toxicity of Crataegus (Hawthorn). Int J Toxicol 13(2):103–111CrossRef Schlegelmilch R, Heywood R (1994) Toxicity of Crataegus (Hawthorn). Int J Toxicol 13(2):103–111CrossRef
go back to reference Tankanow R, Tamer HR, Streetman DS, Smith SG, Welton JL, Annesley T et al (2003) Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 43(6):637–642PubMed Tankanow R, Tamer HR, Streetman DS, Smith SG, Welton JL, Annesley T et al (2003) Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 43(6):637–642PubMed
go back to reference Tauchert M (2002) Efficacy and safety of Crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 143:910–915PubMedCrossRef Tauchert M (2002) Efficacy and safety of Crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 143:910–915PubMedCrossRef
go back to reference Wellington K, Jarvis B (2001) Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 15:465–489PubMedCrossRef Wellington K, Jarvis B (2001) Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 15:465–489PubMedCrossRef
go back to reference Zick SM, Gillespie B, Aaronson KD (2008) The effect of Crataegus oxycantha special extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Fail 10:587–593PubMedCrossRef Zick SM, Gillespie B, Aaronson KD (2008) The effect of Crataegus oxycantha special extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Fail 10:587–593PubMedCrossRef
Metadata
Title
Effect of Crataegus extract on carbon tetrachloride-induced hepatic damage
Authors
Omar M. E. Abdel Salam
Amany A. Sleem
Nermeen Shafee
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Comparative Clinical Pathology / Issue 6/2012
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-011-1356-7

Other articles of this Issue 6/2012

Comparative Clinical Pathology 6/2012 Go to the issue